Natalie Bavli

Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to the graft-versus-leukemia effect

A. Gnirke, D. Neuberg, D. Keskin, 2020, Science Translational Medicine.

Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to graft-versus-leukemia

A. Gnirke, D. Neuberg, P. Kharchenko, 2020, bioRxiv.

Therapeutic plasma exchange in severe refractory autoimmune heparin‐induced thrombocytopenia with thrombosis

R. Sarode, Natalie Bavli, I. Ibrahim, 2021, British journal of haematology.

Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCT.

M. Mihm, G. Dranoff, J. Ritz, 2017, Blood advances.

Complete ADAMTS13 remission in a patient with refractory autoimmune-mediated thrombotic thrombocytopenic purpura after infliximab.

E. Burstein, R. Sarode, Natalie Bavli, 2021, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Bortezomib in relapsed/refractory immune thrombotic thrombocytopenic purpura: A single-centre retrospective cohort and systematic literature review.

R. Sarode, S. Hofmann, Yu-min P Shen, 2023, British Journal of Haematology.